drugset / Trial / NCT01590758
Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to establish the clinical superiority and the safety of topical pexiganan cream 0.8% plus standard local wound care, as compared to placebo cream plus standard local wound care, in the treatment of mildly infected diabetic foot ulcers.
Timeline
- Start
- 2014-06
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MSI-78 | Unknown | 0.8 % | Topical |
Indications
No indication recorded.